Privately held Iambic said on Monday it has entered a multi-year partnership worth more than $1.7 billion with Japan's Takeda Pharmaceutical to use artificial intelligence to help design ...

Iambic, a clinical-stage life science and technology company that uses artificial intelligence to develop medicines has raised more than $100 million in an oversubscribed financing round. The Nov. 10 ...

There’s a post-”Gladiator,” (and also post-“Lord of the Rings”) soundscape that we kind of expect from period pieces — a certain amount of wagons rolling and armor clanging and chickens chirping and ...

Iambic integrates physics principles into its AI architectures, creating models aimed at going deeper into the chemical space. Iambic's platforms include Enchant, NeuralPLexar and OrbNet. Enchant is a ...

Iambic is a clinical-stage life-science and technology company developing novel medicines using its AI-driven discovery and development platform. Based in San Diego and founded in 2020, Iambic has ...

SAN DIEGO, October 21, 2025--(BUSINESS WIRE)--Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development ...

AI-designed oncology drug candidate IAM1363 showed clinical anti-tumor activity, safety, and tolerability IAM1363 shown to be active across both HER2-wild-type and HER2-mutated cancers, and in ...

Right before the second phase of Honkai Star Rail 3.6, Pure Fiction, one of the title’s endgame activities was refreshed. Players can now challenge it again to obtain a decent amount of Stellar Jade.